Table 3A.

Ovarian nuclear classification matrix for the LDA to distinguish placebo-treated and levonorgestrel-treated versus normal controls, showing percent correct matching of true versus karyometry-predicted classificationa

Karyometry-predicted classification
True classificationPlacebo-treatedNormal controls
Placebo-treated84.5%15.5%
Normal controls25.3%74.7%
Levonorgestrel-treatedNormal controls
Levonorgestrel-treated76.4%23.6%
Normal controls25.3%74.7%